Table 1.
General data obtained from 1049 patients
| Variable | N (%) |
|---|---|
| Age (years ) | 54.5 ± 10.3a (range19-81) |
| Male or female | 681:368 (64.9%:35.1%) |
| BMI (kg/m2) | 21.6 ± 2.9a |
| Preoperative ASA | |
| 1 | 127 (12.1%) |
| 2 | 735 (70.1%) |
| 3 | 177 (16.9%) |
| 4 | 10 (1.0%) |
| History of abdominal surgery | |
| Yes | 98 (9.3%) |
| No | 951 (90.7%) |
| Co-morbidities | |
| Yes | 304 (29.0%) |
| No | 745 (71.0%) |
| New adjuvant chemotherapy | |
| Yes | 36 (3.4%) |
| No | 1013 (96.6%) |
| Surgical procedure | |
| Laparotomy | 991 (94.5%) |
| Laparoscopically-assisted | 58 (5.5%) |
| Surgical range | |
| Distal gastrectomy | 748 (71.3%) |
| Proximal gastrectomy | 53 (5.1%) |
| Total gastrectomy | 181 (17.3%) |
| Combined resection | 67 (6.4%) |
| Surgical time (minutes) | 217.1 ± 51.4a |
| TNM staging | |
| I | 218 (20.8%) |
| II | 210 (20.0%) |
| III | 621 (59.2%) |
| Perioperative blood transfusion | |
| Yes | 256 (24.4%) |
| No | 793 (75.6%) |
| Transferring to ICU post surgery | |
| Yes | 54 (5.1%) |
| No | 995 (94.9%) |
| Hospital stay post surgery (days) | 14.1 ± 4.5a (range 7-49) |
| Clavien-Dindo classification | |
| II | 101 (9.6%) |
| IIIa | 26 (2.5%) |
| IIIb | 11 (1.0%) |
| Iva | 8 (0.8%) |
| IVb | 0 (0%) |
| V | 5 (0.5%) |
ASA: American Society of Anesthesiologist, BMI: Body Mass Index, ICU: Intensive Care Unit.
a
mean ± SD.